| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2015PLoSO..1031464L |
| P356 | DOI | 10.1371/JOURNAL.PONE.0131464 |
| P932 | PMC publication ID | 4489871 |
| P698 | PubMed publication ID | 26134285 |
| P5875 | ResearchGate publication ID | 281362569 |
| P2093 | author name string | Gary R Hudes | |
| Warren D Kruger | |||
| Hyung-Ok Lee | |||
| Aladdin Mustafa | |||
| P2860 | cites work | Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13 | Q24338972 |
| Autophagy modulation as a potential therapeutic target for diverse diseases | Q27010076 | ||
| Cultivation, characterization, and identification of human tumor cells with emphasis on kidney, testis, and bladder tumors | Q67017991 | ||
| Activation of the mTOR signaling pathway in renal clear cell carcinoma | Q79426596 | ||
| Autophagy suppresses RIP kinase-dependent necrosis enabling survival to mTOR inhibition | Q27330047 | ||
| TOR signaling in growth and metabolism | Q27860757 | ||
| Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease | Q28261987 | ||
| Upstream and downstream of mTOR | Q28277365 | ||
| Cancer statistics, 2009 | Q29547625 | ||
| Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma | Q29622918 | ||
| Inhibition of autophagy augments 5-fluorouracil chemotherapy in human colon cancer in vitro and in vivo model | Q33540928 | ||
| Mitochondrial dysfunction and oxidative stress mediate the physiological impairment induced by the disruption of autophagy | Q33588721 | ||
| Single amino-acid changes that confer constitutive activation of mTOR are discovered in human cancer | Q34101115 | ||
| Coordinate autophagy and mTOR pathway inhibition enhances cell death in melanoma | Q34576062 | ||
| Regulation of ribosomal protein S6 phosphorylation by casein kinase 1 and protein phosphatase 1 | Q34624565 | ||
| PKCzeta decreases eNOS protein stability via inhibitory phosphorylation of ERK5. | Q35215421 | ||
| The dynamic nature of autophagy in cancer | Q35393206 | ||
| Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. | Q36470315 | ||
| Predicted mechanisms of resistance to mTOR inhibitors | Q36585744 | ||
| Deconvoluting the context-dependent role for autophagy in cancer | Q36876716 | ||
| The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells | Q36972761 | ||
| Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells | Q37170788 | ||
| Hydroxychloroquine: from malaria to autoimmunity | Q37827403 | ||
| Inhibition of autophagy: a new strategy to enhance sensitivity of chronic myeloid leukemia stem cells to tyrosine kinase inhibitors | Q37830694 | ||
| Mechanisms of mTOR inhibitor resistance in cancer therapy | Q37872670 | ||
| The role of autophagy in cancer: therapeutic implications | Q37924056 | ||
| The role of autophagy in clinical practice | Q37950150 | ||
| Regulation of p27 (Kip1) by mitogen-induced tyrosine phosphorylation | Q38009639 | ||
| mTOR inhibitor RAD001 (everolimus) induces apoptotic, not autophagic cell death, in human nasopharyngeal carcinoma cells | Q39191320 | ||
| Autophagy inhibition promotes paclitaxel-induced apoptosis in cancer cells | Q39555036 | ||
| Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells | Q41031244 | ||
| Comparative antiproliferative activity in vitro of natural interferons alpha and beta for diploid and transformed human cells. | Q41626380 | ||
| Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine. | Q41915692 | ||
| In vitro cultivation of human renal cell cancer. II. Characterization of cell lines | Q42802434 | ||
| Radiation-induced autophagy is associated with LC3 and its inhibition sensitizes malignant glioma cells. | Q46421665 | ||
| Phospho-S6 ribosomal protein: a potential new predictive sarcoma marker for targeted mTOR therapy | Q46834814 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hydroxychloroquine | Q421094 |
| renal carcinoma | Q18556333 | ||
| P304 | page(s) | e0131464 | |
| P577 | publication date | 2015-07-02 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Hydroxychloroquine Destabilizes Phospho-S6 in Human Renal Carcinoma Cells | |
| P478 | volume | 10 |
| Q104617060 | Hydroxychloroquine Inhibits the Trained Innate Immune Response to Interferons |
| Q33745827 | Initial computed tomography imaging details during first-line systemic therapy is of significant prognostic value in patients with naïve, unresectable metastatic renal cell carcinoma |
| Q92753000 | Involvement of Actin in Autophagy and Autophagy-Dependent Multidrug Resistance in Cancer |
| Q39021076 | Research progress of hydroxychloroquine and autophagy inhibitors on cancer. |
| Q39378223 | Targeting Autophagy in Cancer: Update on Clinical Trials and Novel Inhibitors. |
| Q88406511 | Targeting autophagy in cancer |
| Q64976486 | Targeting autophagy using metallic nanoparticles: a promising strategy for cancer treatment. |
| Q41964740 | Type Iγ phosphatidylinositol phosphate kinase regulates PD-L1 expression by activating NF-κB. |
Search more.